Skip to main content

Table 1 Baseline patient characteristics

From: Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus

 

DEB-TACE (n = 42)

C- TACE (n = 41)

P-Value

Sex (Male/Female)

40/2

37/4

0.649*

Age

52.7 ± 12.1

53.0 ± 10.3

0.908

Child–Pugh Score

0.447#

 A

32

34

 

 B

10

7

 

Liver Functions

 TBILI (umol/L)

19.1 ± 13.1

20.1 ± 12.7

0.721

 Albumin (g/L)

37.6 ± 4.8

37.2 ± 6.8

0.781

 PT-sec (sec)

14.3 ± 1.0

14.5 ± 1.1

0.483

AFP Value

0.447#

 ≤ 400 ng/ml

17

20

 

 > 400 ng/ml

25

21

 

Capsular Infiltration

0.446#

 Non-infiltration

15

18

 

 Infiltration

27

23

 

Tumor maximum size

0.555#

 ≤ 5 cm

8

10

 

  > 5 cm

34

31

 

Tumor Numbers

0.383#

 Single

7

10

 

 Multiple

35

31

 

APS

0.591#

 Present

16

18

 

 Absent

26

23

 

HVI

0.395#

 Present

26

29

 

 Absent

16

12

 

EHS

0.584#

 Present

12

14

 

 Absent

30

27

 
  1. AFP alpha fetoprotein, APS ArterioPortal Shunt, HVI Hepatic Vein Invasion, EHS Extra Hepatic Spread
  2. *continuity corrections was used
  3. #Pearson Chi-square was used